Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.gie.2025.01.013 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Practical management of mild-to-moderate ulcerative colitis: an international expert consensus.
Expert Rev Gastroenterol Hepatol
August 2024
Gastroenterology and Endoscopy, IRCCS San Raffaele Hospital, Milan, Italy.
Introduction: Although there are well-defined guidelines for the management of mild-to-moderate ulcerative colitis (UC), there are still unmet needs. For this reason, we conducted an international expert consensus to standardize the management of patients with mild-to-moderate UC and provide practical guidance to clinicians.
Areas Covered: Based on Delphi methodology, 15 statements were approved after two rounds of voting, addressing several aspects of disease management from sequencing to treatment duration, from monitoring to optimization techniques and safety profile.
Drug Optimization in Patients with Mild-to-Moderate Ulcerative Colitis: A Global Survey.
J Clin Med
April 2024
Department of Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele and Vita-Salute San Raffaele University, 20132 Milan, Italy.
: The treatment of patients with mild-to-moderate ulcerative colitis (UC) is challenging. Although there are commonly used guidelines, therapy optimization is not standardized. We conducted a survey to investigate the management and treatment of patients with mild-to-moderate UC.
View Article and Find Full Text PDFWARNING TO DELAY IN DIAGNOSING MICROSCOPIC COLITIS IN OLDER ADULTS. A SERIES OF CASES.
Arq Gastroenterol
March 2024
Universidade Federal do Paraná, Curitiba, PR, Brasil.
Background: Microscopic colitis (MC) is a chronic inflammatory bowel disease causing non-bloody diarrhea, and several cases are undiagnosed as a hidden cause of chronic diarrhea.
Objective: We aimed to report the symptoms, delay diagnosis and the treatment of MC in a case series.
Methods: All patients were treated at a Gastroenterology reference office from May 2022 to June 2023.
Management and treatment optimization of patients with mild to moderate ulcerative colitis.
Expert Rev Clin Immunol
March 2024
Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele and Vita-Salute San Raffaele University, Milan, Italy.
Introduction: Ulcerative colitis (UC) is a chronic inflammatory bowel disease with a significant health-care burden worldwide. While medical therapy aims to induce and maintain remission, optimal management of mild to moderate UC remains challenging due to heterogeneity in severity classifications and non-standardized approaches. This comprehensive review summarizes current evidence and knowledge gaps to optimize clinical decision-making in patients with mild to moderate UC.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!